Heme oxygenase-1 induction in the brain during lipopolysaccharide-induced acute inflammation by Maeda, Shigeru et al.
© 2008 Maeda et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article 
which permits unrestricted noncommercial use, provided the original work is properly cited.
Neuropsychiatric Disease and Treatment 2008:4(3) 663–667 663
ORIGINAL RESEARCH
A
Heme oxygenase-1 induction in the brain during 
lipopolysaccharide-induced acute inﬂ  ammation
Shigeru Maeda1
Ichiro Nakatsuka1
Yukiko Hayashi1
Hitoshi Higuchi1
Masahiko Shimada2
Takuya Miyawaki1
1Department of Dental 
Anesthesiology, Okayama University 
Hospital, Okayama, Japan; 2Orofacial 
Pain Management, Department of 
Oral Restitution, Graduate School, 
Tokyo Medical and Dental University, 
Tokyo, Japan
Correspondence: Shigeru Maeda
Department of Dental Anesthesiology, 
Okayama University Hospital, 2-5-1 
Shikata-cho, Okayama 700-8525, Japan
Tel +81 86 235 6721
Fax +81 86 235 6721
Email maedas@md.okayama-u.ac.jp
Abstract: Delirium occurs in 23% of sepsis patients, in which pro-inﬂ  ammatory cytokines and 
nitric oxide are suggested to be involved. However, in animal experiments, even a subseptic dose 
of lipopolysaccharide (LPS) injection induces both pro-inﬂ  ammatory cytokines and inducible 
nitric oxide synthase in the brain, suggesting that the brain oxidative reaction can be induced 
in the subseptic condition. Then, we evaluated the changes of heme oxygenase-1 (HO-1), a 
sensitive oxidative marker, as well as interleukin (IL)-1β, IL-6, and inductible nitric oxide syn-
thase (iNOS) mRNA in the hypothalamus and hippocampus of rats using real-time PCR after 
peripheral injection of LPS (2.0 mg/kg). As a result, these four kinds of mRNAs were induced 
signiﬁ  cantly in both areas after LPS injection. These results suggest that peripheral inﬂ  amma-
tion induces an oxidative reaction in the brain, even if the inﬂ  ammation is not lethal. It is also 
considered that several pathways are involved in brain HO-1 induction.
Keywords: heme oxygenase-1, interleukin-1β, interleukin-6, lipopolysaccharide, hypothalamus, 
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Introduction
Delirium occurs in 23% of sepsis patients (Sprung et al 1990), and the term sepsis-
associated delirium (SAD) has been proposed (Ebersoldt et al 2007). Using magnetic 
resonance imaging, multiple ischemic strokes and white matter lesions were observed 
in the brain of a SAD patient (Sharshar et al 2007). As part of the mechanism under-
lying SAD, pro-inﬂ  ammatory cytokines and inducible nitric oxide synthase (iNOS) 
are considered to play important roles in brain damage (Sharshar et al 2003). Since 
antioxidants have been reported to provide effective treatment in a sepsis model (Abd 
El-Gawad and Khalifa 2001) and NO induces free radicals leading to apoptosis in 
neuronal cells, the oxidative reaction is considered to be one of the foci of SAD.
In a sepsis model, more than 10 mg/kg of lipopolysaccharide (LPS) is administered 
by intraperitoneal or intravenous injection (Fujiwara et al 1999; Birnbaum et al 2006). 
However, after peripheral injection of even a subseptic dose (2.0 mg/kg or less) of LPS, 
interleukin-1β (IL-1β), IL-6, and iNOS mRNA are induced in the brain (Vallieres and 
Rivest 1997; Tonelli et al 2003; Singh and Jiang 2004). So far, it is unclear whether 
oxidative reactions are caused in the brain after peripheral injection of a subseptic dose 
of LPS. Thus, we investigated further. Brain heme-oxygenase-1 (HO-1) mRNA levels 
were measured quantitatively using real-time PCR because HO-1 responds sensitively 
to many kinds of oxidative stress (Ryter and Choi 2002).
The hypothalamus and hippocampus were chosen for analysis because the hypo-
thalamus is known to be sensitive to ip injection of LPS (Tonelli et al 2003), and the 
hippocampus is denatured in neurodegenerative diseases, which has been suggested 
to involve an interaction between HO-1 and inﬂ  ammatory cytokines (Mattson and 
Magnus 2006).Neuropsychiatric Disease and Treatment 2008:4(3) 664
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Materials and methods
Animals and treatment
Male Sprague-Dawley rats were obtained from Shimizu 
Laboratory Supplies (Kyoto, Japan) at ﬁ  ve weeks of age. 
The animals were housed in groups of two or three per cage 
at a constant temperature of 25 °C with standard food pellets 
and water available ad libitum. All animals were maintained 
on a 12:12 L/D cycle (lights on at 0700 h). Between 0800 h 
and 1000 h the animals were injected intraperitoneally with 
2.0 mg/kg LPS (e-coli 055 B5) (Sigma, St. Louis, MO), 
according to a previous study (Eriksson et al 2000; Tonelli 
et al 2003), in which an immune reaction was shown to 
be induced in the brain. Animals were decapitated 3, 6, 
and 12 hr after the injection. Just before decapitation, the 
animals were perfused with normal saline solution to avoid 
contamination of blood under anesthesia by pentobarbital. 
As a control, rats with no treatment were killed in the 
same manner. The hypothalamus and hippocampus were 
dissected on an ice-cooled glass plate with an established 
method (Glowinski and Iversen 1966). Both parts were 
immersed in RNA later (Qiagen, Hilden, Germany), and 
kept at –20 °C. Treatment of the rats was approved by the 
Okayama University Dental School Animal Care and Use 
Committee.
Total RNA extraction and cDNA 
synthesis
Total RNA was extracted from the brain samples using 
Trisol (Invitrogen, Carlsbad, CA), and residual genomic 
DNA was removed by incubating the RNA sample with 
RNase-free DNaseI (Takara, Tokyo, Japan). Then, total 
RNA was extracted with phenol, followed by ethanol 
precipitation. Total RNA was reverse-transcribed to cDNA 
by AMV reverse transcriptase (Roche Diagnostics, Basel, 
Switzerland), according to the manufacturer’s instructions, 
followed by 20 times’ dilution with ultra-pure water.
Quantitative real-time PCR analysis
Forward (F) and reverse (R) primers used to amplify genes 
are listed in Table 1. Quantitative real-time PCR for HO-1 
was performed using a LightCycler (Roche Diagnostics, 
Basel, Switzerland). Reactions were performed in a 10 µl 
volume with 0.5 µM primers using LightCycle-DNA Master 
SYBR Green I mix (Roche Diagnistics, Basel, Switzerland). 
The reactions were incubated at 95 °C for 10 min, followed 
by a cycling protocol consisting of three stages: 20 s at 
95 °C for denaturation, 20 s at 69 °C for annealing, and 
20 s at 72 °C for extension. IL-1β, IL-6, and iNOS mRNAs 
were analyzed with Miniopticon (Bio-rad, Hercules, CA). 
Reactions were performed in a 20 µl volume with 0.5 µM 
primers using iQ SYBR Green Supermix (Bio-rad, Hercu-
les, CA). After incubation at 95 °C for 10 min, the cycling 
protocol was performed. The cycling protocol for IL-1β was 
as follows: 10 s at 95 °C for denaturation, 20 s at 61 °C for 
annealing, and 10 s at 72 °C for extension. For the reaction 
of IL-6 and iNOS mRNA, the annealing temperature was 
set at 64 °C and 59 °C, respectively. The ﬂ  uorescence signal 
was detected at the end of the extension period. After the 
ﬁ  nal cycle of PCR, melting curve analysis was performed 
routinely.
The speciﬁ  city of ampliﬁ  cation was also conﬁ  rmed by 
agarose gel electrophoresis. The starting cDNA copy number 
of each gene of interest in the cDNA sample was calculated 
by comparison with the corresponding standard curve, and 
the target cDNA copy number was normalized to the cDNA 
copy number of β-actin ampliﬁ  ed from the same cDNA 
sample. For standard curves, speciﬁ  c plasmids were made for 
each sequence, and they were diluted to six concentrations 
as standards. Data were analyzed using ANOVA followed 
by Dunnet’s multiple comparison test.
Results
After all PCR reactions, only one peak was observed for 
each set of primers in melting curve analysis, and only 
one band was detected at the expected size by agarose gel 
electrophoresis.
Changes of HO-1 mRNA (Figure 1)
In both the hypothalamus and hippocampus, HO-1 mRNA 
levels were signiﬁ  cantly increased 6 hr after the injection of 
LPS. In both areas, the levels decreased 12 hr after the injec-
tion, becoming comparable to the control levels. By 6 hrs, 
HO-1 mRNA was enhanced up to 2-fold in the hypothalamus, 
and 3-fold in the hippocampus.
Table 1 Primers used for the ampliﬁ  cation of cDNAs
cDNA   Sequence (5'-3')  Location 
(accession in  cDNA
No.) 
HO-1 F:  CGTGCAGAGAATTCTGAGTTC  195–215
(NM 012580) R:  AGACGCTTTACGTAGTGCTG  469–450
IL-1 beta  F: ATGCCTCGTGCTGTCTGACC  472–491
(M98820) R:  CCATCTTTAGGAAGACACGGGTT  889–867
IL-6 F:  AGCGATGATGCACTGTCAGA  299–318
(M26744) R:  GGTTTGCCGAGTAGACCTCA 697–678
iNOS F:  GCAGGTTGAGGATTACTTCTTCCA  3505–3528
(NM 012611) R:  GCCCTTTTTTGCTCCATAGGAAA 3597–3576
beta actin  F: CCTGTATGCCTCTGGTCGTA  504–523
(NM 031144) R:  CCATCTCTTGCTCGAAGTCT  763–744Neuropsychiatric Disease and Treatment 2008:4(3) 665
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Changes of IL-1β mRNA (Figure 2)
IL-1β mRNA was increased up to 33-fold 6 hrs after LPS 
injection in the hypothalamus and 24-fold 6 hr after injection 
in the hippocampus. Signiﬁ  cant differences were observed 
6 hr after injection in both areas compared with the control.
Changes of IL-6 mRNA (Figure 3)
After 6 hrs, the level of IL-6 mRNA was increased up to 
8-fold and 19-fold in the hypothalamus and hippocampus, 
respectively. Signiﬁ  cant differences were observed 6 hr after 
injection in both areas.
Changes of iNOS mRNA (Figure 4)
In the hypothalamus, iNOS mRNA was increased up to 6000-
fold 3 hrs after LPS injection compared with the control. 
The average levels 6 and 12 hrs after injection were higher 
than the control but there was no signiﬁ  cant difference. 
In the hippocampus, the level of iNOS mRNA increased up 
to more than 80-fold 3 and 6 hrs after LPS injection. The 
average value 12 hrs after injection was higher than the 
control but there was no signiﬁ  cance.
Discussion
Brain HO-1 mRNA responded to peripheral injection of 
LPS in association with IL-1β, IL-6, and iNOS. Although 
inductions of IL-1β, IL-6, and iNOS were demonstrated 
after peripheral LPS injection in previous reports (Vallieres 
and Rivest 1997; Satta et al 1998; Tonelli et al 2003), this 
is the ﬁ  rst study showing that HO-1, IL-1β, IL-6, and iNOS 
mRNA were induced in the same brain after peripheral 
injection of LPS.
The response of iNOS mRNA was quick and very strong 
in this experiment. NO, generated by iNOS, leads to the 
induction of free radicals (Moncada and Bolanos 2006), 
Figure 2 Changes in IL-1β mRNA. IL-1β mRNA markedly increased 6 hrs after LPS 
injection in both the hypothalamus (A) and hippocampus (B). Data represent the 
mean ± SE. (n = 4–6, **:p  0.01, *:p  0.05).
Figure 1 Changes in HO-1 mRNA. HO-1 mRNA increased 6 hrs after LPS injection 
signiﬁ  cantly in both the hypothalamus (A) and hippocampus (B). Data represent the 
mean ±SE. (n = 4–6, *:p  0.05).
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and NO is reported to contribute to HO-1 induction in the 
brain (Kitamura et al 1998). Therefore, it is considered that 
brain HO-1 induction is mediated with iNOS in this experi-
ment. Peripheral LPS injection induces brain I-κBα (Quan 
et al 1997), and NF-κB, released from I-κBα, initiates the 
transcription of HO-1 (Lavrovsky et al 1994; Wijayanti et al 
2004). This pathway is considered to be involved in this 
study. In addition, as IL-6 induces HO-1 mRNA through the 
JAK/stat pathway in the liver (Tron et al 2006), this mecha-
nism may also work in the brain. Peripheral acute inﬂ  amma-
tion caused by LPS induces HO-1 mRNA, and this reaction 
is considered to be involved in several mechanisms.
In the hypothalamus, HO-1 mRNA could not be detected 
after LPS injection with classical RT-PCR (Jacobs et al 
1997). However, real-time PCR is sufﬁ  ciently sensitive to 
quantify all three constitutive types of HO genes in each part 
of the brain (Scapagnini et al 2002). In previous studies using 
Figure 4 Changes in iNOS mRNA. iNOS mRNA markedly increased 3 hrs after 
LPS injection in the hypothalamus (A) In the hippocampus, the level of iNOS mRNA 
increased 3 and 6 hrs after LPS injection (B) Data represent the mean ± SE. (n = 4–6, 
*:p  0.05).
Figure 3 Changes in IL-6 mRNA. IL-6 mRNA increased 6 hrs after LPS injection in 
both the hypothalamus (A) and hippocampus (B). Data represent the mean ± SE. 
(n = 4–6, **:p  0.01, *:p  0.05).
in situ hybridization, after peripheral injection of LPS, IL-1β, 
IL-6, and iNOS were shown to be induced in circumventricu-
lar organs (CVOs) and the paraventricular nucleus, included 
in the hypothalamus in this study (Wong et al 1996; Vallieres 
and Rivest 1997; Tonelli et al 2003). Since oxidative stress is 
considered to arise in these areas due to cytokines and NO, 
HO-1 mRNA may be induced there, resulting in a signiﬁ  -
cant increase in HO-1 mRNA in the hypothalamus shown 
in this study. In the hippocampus, signals of these cytokines 
or iNOS have never been detected by in situ hybridization 
(Wong et al 1996; Vallieres and Rivest 1997; Tonelli et al 
2003). In this study, HO-1 mRNA increased along with the 
other three genes, suggesting that the hippocampus reacts to 
LPS injection with overall sensitivity, but not at a sensitive 
area like CVOs.
A subseptic dose of LPS injection caused HO-1 reaction 
in the brain, suggesting that acute peripheral inﬂ  ammation 
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causes oxidative stress in the brain even if the inﬂ  ammation 
is not lethal. Several kinds of pathways are considered to 
be involved in the mechanism of brain HO-1 induction. In 
a future study, other oxidative changes should be evaluated. 
Regarding the clinical situation, in a person with peripheral 
inﬂ  ammation, such as patients after surgery, brain oxidative 
changes may be induced.
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